In a deal expected to close this month, pharma collaborator Halozyme has picked up a $150 million credit deal based on future royalties from its Enhanze line…

Seattle's Presage Biosciences has in-licensed Phase I oral cancer drug voruciclib from India's Piramal Enterprises to test its intratumoral…

Cambridge, MA's Bind Therapeutics announced that patient administration of its Accurins nanoparticles has commenced in the trial of an Astra Zeneca…

Novo Nordisk announced an expanded drug delivery partnership with Emisphere under which the Big Pharma will develop medications for metabolic disorders like…

3M announced that it is helping Impel Neuoropharma develop its Precision Olfactory Delivery for delivery of neurological drugs into the brain and nervous…

GlaxoSmithKline now has rights to develop inhaled therapeutics using Liquidia's PRINT particle engineering technology. The development builds on a drug…

As part of its so-called Base Plus Plus Plus strategy, specialty pharmaceutical company Perrigo announced that it is licensing Flamel's LiquiTime…

Aerie Pharmaceuticals will use GrayBug's micro particle-based technologies to deliver its candidates to the front and back of the eye under a just-…